FSB BIOPHARMA CONSULTING LTD
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10Company Documents
| Date | Description |
|---|---|
| 07/03/257 March 2025 | Micro company accounts made up to 2025-02-28 |
| 28/02/2528 February 2025 | Annual accounts for year ending 28 Feb 2025 |
| 09/02/259 February 2025 | Confirmation statement made on 2025-02-09 with no updates |
| 02/01/252 January 2025 | Registered office address changed from 45 Queen Street Deal Kent CT14 6EY United Kingdom to Tanglewood Patrixbourne Road Bridge Canterbury Kent CT4 5BL on 2025-01-02 |
| 25/06/2425 June 2024 | Total exemption full accounts made up to 2024-02-29 |
| 29/02/2429 February 2024 | Annual accounts for year ending 29 Feb 2024 |
| 12/02/2412 February 2024 | Confirmation statement made on 2024-02-09 with no updates |
| 06/04/236 April 2023 | Total exemption full accounts made up to 2023-02-28 |
| 10/02/2310 February 2023 | Confirmation statement made on 2023-02-09 with no updates |
| 13/10/2213 October 2022 | Total exemption full accounts made up to 2022-02-28 |
| 28/02/2228 February 2022 | Annual accounts for year ending 28 Feb 2022 |
| 14/02/2214 February 2022 | Confirmation statement made on 2022-02-09 with no updates |
| 10/11/2110 November 2021 | Total exemption full accounts made up to 2021-02-28 |
| 28/02/2128 February 2021 | Annual accounts for year ending 28 Feb 2021 |
| 10/02/2010 February 2020 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company